IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 93 filers reported holding IMMUNOMEDICS INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,321,000 | +15.1% | 360,037 | +2.0% | 0.00% | +100.0% |
| Q3 2016 | $1,148,000 | +41.7% | 353,111 | +1.1% | 0.00% | 0.0% |
| Q2 2016 | $810,000 | -6.1% | 349,301 | +1.2% | 0.00% | 0.0% |
| Q1 2016 | $863,000 | -16.9% | 345,085 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $1,039,000 | +80.1% | 338,296 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $577,000 | -58.5% | 335,194 | -2.2% | 0.00% | -50.0% |
| Q2 2015 | $1,391,000 | +48.3% | 342,608 | +39.8% | 0.00% | +100.0% |
| Q1 2015 | $938,000 | -19.4% | 244,996 | +1.0% | 0.00% | -50.0% |
| Q4 2014 | $1,164,000 | +26.7% | 242,468 | -1.8% | 0.00% | +100.0% |
| Q3 2014 | $919,000 | +4.3% | 247,022 | +2.3% | 0.00% | 0.0% |
| Q2 2014 | $881,000 | +1.1% | 241,498 | +16.7% | 0.00% | 0.0% |
| Q1 2014 | $871,000 | -8.3% | 206,966 | +0.2% | 0.00% | 0.0% |
| Q4 2013 | $950,000 | -27.2% | 206,490 | -1.9% | 0.00% | -50.0% |
| Q3 2013 | $1,305,000 | +20.7% | 210,540 | +5.9% | 0.00% | 0.0% |
| Q2 2013 | $1,081,000 | – | 198,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |